Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Change in Accured Expenses (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Change in Accured Expenses for 13 consecutive years, with $15.9 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 376.41% year-over-year to $15.9 million; the TTM value through Mar 2026 reached $27.8 million, up 275.25%, while the annual FY2025 figure was $6.2 million, 6.05% up from the prior year.
  • Change in Accured Expenses hit $15.9 million in Q1 2026 for Viking Therapeutics, up from $2.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $15.9 million in Q1 2024 and bottomed at -$13.6 million in Q2 2024.
  • Average Change in Accured Expenses over 5 years is $1.9 million, with a median of $694000.0 recorded in 2022.
  • Year-over-year, Change in Accured Expenses crashed 862.72% in 2023 and then surged 6472.88% in 2024.
  • Viking Therapeutics' Change in Accured Expenses stood at $2.5 million in 2022, then surged by 57.26% to $3.9 million in 2023, then plummeted by 299.8% to -$7.8 million in 2024, then soared by 126.37% to $2.1 million in 2025, then skyrocketed by 667.81% to $15.9 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $15.9 million, $2.1 million, and -$4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.